Relief Therapeutics to Present Pre-Clinical Evidence for Improved Amino Acid Utilization with PKU GO

Relief Therapeutics Holding SA / Key word(s): Study results17-March-2023 / 22:45 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Therapeutics to Present Pre-Clinical Evidence for Improved Amino Acid Utilization with PKU GOLI...

Related Keywords

Salt Lake City ,Utah ,United States ,Italy ,Germany ,Geneva ,Genè ,Switzerland ,Rome ,Lazio ,Balerna ,Switzerland General ,Swiss ,Irina Koffler ,Catherine Day ,Nermeen Varawalla ,Exchange Commission ,Ir Communications ,Relief Therapeutics Holding Sa Key ,Society For Inherited Metabolic Disorders ,Pharma Research ,Swiss Exchange ,Physiomimic Technology ,Relief Therapeutics Holding ,Present Pre Clinical Evidence ,Improved Amino Acid Utilization ,Inherited Metabolic Disorders ,Annual Meeting ,Relief Therapeutic ,More Physiological Absorption ,Prolonged Release Amino Acid Supplement ,Preclinical Evidence ,Improved Amino Acid ,Hyatt Regency ,Salt Lake ,Katie Draper ,Relief Therapeutics ,Physiological Absorption ,Molecular Genetics ,Genetic Landscape ,